Global Antifungal Drugs Market (2018 to 2024) – Assess Future Growth Opportunities

DUBLIN–(BUSINESS WIRE)–The “Antifungal Drugs: Technologies and Global Markets” report has been added to ResearchAndMarkets.com’s offering.

The aim of this report is to initially conduct a review of the antifungal drugs currently available, explore the issues facing the use of antifungal drugs and review some of the latest developments of new and innovative antifungal drugs, their technologies and their intended clinical applications. The key objective is also to conduct and provide an analysis of the market value, growth rates, market shares and market development, and examine the market dynamics and market factors influencing the growth and development of this market.

This report also looks at the challenges and potential threats facing the industry and the factors influencing the market shares of the major market suppliers as well as smaller manufacturers in local markets.

Companies Mentioned

• Anacor Pharmaceuticals, Inc.
• Astellas Pharma Inc.
• Bausch Health Companies Inc.
• Bayer Ag
• Cidara Therapeutics Inc.
• Dr. Reddy’s Laboratories Ltd.
• Enzon Pharmaceuticals, Inc.
• Ferrer Internacional S.A.
• Galderma Pharma S.A.
• Gilead Sciences Inc.
• Glenmark Pharmaceuticals Ltd.
• Janssen Pharmaceuticals Inc. (Johnson & Johnson)
• Leadiant Biosciences Inc.
• Merck & Co., Inc.
• Merz Pharma Gmbh & Co. Kgaa
• Moberg Pharma Ab
• Mylan Laboratories Inc.
• Pfizer Inc.
• Sanofi S.A.
• Taro Pharmaceutical Industries Ltd.
• Teva Pharmaceuticals Industries Ltd.

Report Includes:

• 116 data tables and 27 additional tables
• An overview of the global markets for antifungal drugs within the pharmaceuticals industry
• Analyses of the global market trends, with data corresponding to market size from 2018 and 2019, and projections of compound annual growth rates (CAGRs) through 2024
• Comparative study of the two primary segments of antifungal medications – over-the-counter (OTC) and prescription based – and issues facing the use of these products
• Briefing about therapeutics in early development such as new molecular and biological entities from traditional pharmaceutical sources, naturally derived synthetic chemicals, and biological sources
• Review of antifungal agents and their classification based on the mechanism of action, approved therapeutic products and relevant patents with their expiration dates
• Information pertaining to R&D efforts, breakthrough therapy innovations, clinical trials of novel drug developments, their technologies and intended clinical applications
• Market share analysis of leading suppliers of antifungal drugs with related information about specific products, and their key competitive landscape

Key Topics Covered:

1 Introduction

2 Summary and Highlights

3 Introduction to Fungi and the Antifungal Drug Market

• Introduction to Fungi
• Classification of Fungi
• Chytridiomycota
• Blastocladiomycota
• Neocallimastigomycota
• Microsporidia
• Ascomycota (Sac Fungi)
• Basidiomycota (Club Fungi)
• Glomeromycota
• Scope of Application: Human Healthcare
• Types and Descriptions of Fungi Diseases in Humans
• Aspergillosis
• Blastomycosis
• Candidiasis
• Coccidioidomycosis (Valley Fever)
• Coccidioidomycosis (Cryptococcosis)
• Dermatophytosis
• Fungal Infections of the Eye
• Histoplasmosis
• Onychomycosis (Fungal Nail Infections)
• Mucormycosis (Zygomycosis)
• Mycetoma
• Paracoccidioidomycosis
• Pneumocystis Pneumonia
• Pseudallescheriasis
• Sporotrichosis
• Rare Fungal Infections and Disorders
• Risk Factors Associated with Human Fungal Infections
• Use of Antibiotics
• Use of Corticosteroids
• Specific Medical Conditions
• Central Line-Associated Bloodstream Infections
• Surgery
• Organ Transplantation
• Environmental Factors
• Hereditary Factors
• Hospitalization

4 Common Environmental Fungi

• Molds and the Human Issues Associated with Them
• Why Environmental Mold is a Unique Problem
• Health Risks due to Environmental Fungi and Mold
• Environmental Molds
• Alternaria
• Aspergillus
• Cladosporium
• Penicillium
• Eurotium
• Rhizopus
• Mucor
• Geotrichum
• Fusarium
• Stachybotrys
• Wallemia
• Trichothecium
• Scopulariopsis Brevicaulis
• Scytalidium Dimidiatum
• Trichoderma
• Paecilomyces Variotii

5 Review of Antifungal Agents

• Introduction to Antifungal Agents
• Classification of Antifungal Agents
• Systemic Antifungal Drugs
• Polyene Antibiotics
• Azole Antifungals
• Echinocandins
• Antimetabolite: Flucytosine (5-FC)
• Other Systemic Antifungal Agents
• Topical Antifungal Drugs
• Topical Polyene Antibiotics
• Azoles-Imidazole
• Others
• Naturally Occurring Alternatives

6 New and Innovative Antifungals: Current Developments, Clinical Trials and Product Pipelines

• The Need for New and Innovative Antifungals
• Strategic Approach to the Development of New Antifungal Agents
• Identification of Bioactive Compounds
• Nanostructured Antifungals
• Drug Repositioning
• Vaccine Development Against Fungal Diseases
• Artificial Intelligence-Based Platform Technology (FungalAi)
• Emerging Targets and Molecular Scaffolds
• New Antifungal Drugs in Development
• Most Notable Antifungal Compounds
• Specific Company Product Pipelines
• Mycovia Pharmaceuticals
• Amplyx Pharmaceuticals
• F2G
• NovaBiotics Ltd.
• Appili Therapeutics Inc.
• Scynexis Inc.
• Bright Angel Therapeutics
• Valley Fever Solutions

7 Global Market for Antifungal Medications

• Introduction
• Market Revenue Analysis
• Global Market Revenue Analysis
• Regional Overview
• Major Developments and Trends in Antifungal Drug Treatment and Technologies
• Prescription Antifungal Drugs
• OTC Antifungal Drugs
• Market Share Analysis

8 North American Market for Antifungal Drugs

9 European Market for Antifungal Drugs

10 Asia-Pacific Market for Antifungal Drugs

11 Latin American Market for Antifungal Drugs

12 Middle Eastern/African Market for Antifungal Drugs

13 Company Profiles

For more information about this report visit https://www.researchandmarkets.com/r/vxgw2l

Contacts

ResearchAndMarkets.com

Laura Wood, Senior Press Manager

[email protected]
For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900